Showing 115 of 115on this page. Filters & sort apply to loaded results; URL updates for sharing.115 of 115 on this page
Infographic: GiACTA - Trial of Tocilizumab in Giant-Cell Arteritis | Eye
OP0135 Tocilizumab in giant cell arteritis: giacta trial versus a ...
The GiACTA trial: Tocilizumab in Giant Cell Arteritis | vasculitides
GiACTA Study Shows Benefit of Adding Tocilizumab to Steroid Taper in ...
Three-year GiACTA trial results revealed - Medical Republic
Phase 3 GiACTA Trial Results for TCZ in Giant Cell Arteritis ...
Giant Cell Arteritis: Timely Diagnosis and Emerging Treatment ...
巨細胞性動脈炎の80歳以上の患者へのTocilizumabの有効性・安全性 - 膠原病・リウマチ一人抄読会
Design of the Tocilizumab in Giant Cell Arteritis Trial - Unizony ...
Profile of tocilizumab and its potential in the treatment of giant cel | EB
Long-term effect of tocilizumab in patients with giant cell arteritis ...
Trial of Tocilizumab in Giant-Cell Arteritis | NEJM
Table 1 from Design of the Tocilizumab in Giant Cell Arteritis Trial ...
Pharmacokinetics and Pharmacodynamics of Tocilizumab in Combination ...
Effects of Baseline Prednisone Dose on Remission and Disease Flare in ...
Time to Flare in Patients with New-Onset versus Relapsing Giant Cell ...
POS0799 THE EFFICACY AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH GIANT ...
Treatment of Giant Cell Arteritis (GCA)
(PDF) Tocilizumab in giant cell arteritis: differences between the ...
(PDF) A Multicenter Series of Giant Cell Arteritis Patients from ...
Efficacy of Adjunctive Methotrexate in Patients with Giant Cell ...
(PDF) The Effects of Treatment on Body Mass Index in Giant Cell ...
My Treatment Approach to Giant Cell Arteritis - Mayo Clinic Proceedings
Figure 1 from Design of the Tocilizumab in Giant Cell Arteritis Trial ...
FRI0262 CLINICAL OUTCOMES OF PATIENTS WITH GIANT CELL ARTERITIS WITH ...
FRI0220 EFFICACY OF ADJUNCTIVE METHOTREXATE IN PATIENTS WITH GIANT CELL ...
Characteristics of Giant Cell Arteritis Flares After Successful ...
Immediate versus gradual TocilizuMab discontinuAtion in GIant Cell ...
OP0140 LONG-TERM OUTCOME OF TOCILIZUMAB FOR PATIENTS WITH GIANT CELL ...
Trial of Tocilizumab in Giant-Cell Arteritis | New England Journal of ...
Advances in the Treatment of Giant Cell Arteritis
OP0131 Optimal dose of tocilizumab for the treatment of giant cell ...
Tocilizumab for induction and maintenance of remission in giant cell ...
Tocilizumab Giant Cell Arteritis | PDF | Clinical Trial | Dose ...
Tocilizumab improves remission rates in giant-cell arteritis: The ...
GiACTA: Giant cell arteritis remission maintained in 42% of patients ...
Proposed algorithm for the use of tocilizumab in giant cell arteritis ...
Treatment algorithm for giant cell arteritis (GCA). | Download ...
Tocilizumab monotherapy after ultra-short glucocorticoid administration ...
Treatment for giant cell arteritis with 8 weeks of prednisone in ...
Giant Cell Arteritis - Vasculitis Foundation
Tocilizumab in giant cell arteritis. Main observational studies ...
(PDF) New-onset versus relapsing giant cell arteritis treated with ...
Giant-Cell Arteritis: What's the evidence for steroid-sparing therapies ...
Giant cell arteritis: Current treatment and management
Tocilizumab in Monotherapy vs. Combined in Aortitis Associated with ...
Giant Cell Arteritis: An Update on Diagnosis and Management
Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study ...
Efficacy of tocilizumab in giant cell arteritis patients with transient ...
Efficacy and Safety of Tocilizumab in Patients with Giant Cell ...
Intravenous tocilizumab for the treatment of giant cell arteritis: a ...
Frontiers | Timing of Tocilizumab Administration Under the Guidance of ...
Baseline Glucocorticoid Toxicity in the Treatment of Giant Cell ...
Measuring treatment outcomes and change in disease activity in giant ...
(PDF) Baseline Glucocorticoid‐Related Toxicity Scores in Giant Cell ...
| BTT | Dove Medical Press
Complete resolution of giant cell arteritis after tocilizumab ...
(PDF) Giant Cell Arteritis treatment failure during Tocilizumab therapy
Tocilizumab for Giant Cell Arteritis in Japan over 2 Years: A ...
Patients’ Baseline Characteristics, but Not Tocilizumab Exposure ...
Tocilizumab Ups Giant Cell Arteritis Remissions in Early Trial
Tocilizumab delays flare, reduces glucocorticoid dose in new-onset ...
FDA Approved Tocilizumab Drug for Giant Cell Arteritis
The Efficacy and Safety of Tocilizumab in Patients with Giant Cell ...
(PDF) Benchmarking tocilizumab use for giant cell arteritis
(PDF) Treatment of Giant Cell Arteritis Using Tocilizumab
(PDF) AB0577 TOCILIZUMAB IN GIANT CELL ARTERITIS. ROUTE OF ...
Giant Cell Arteritis And The Rapid Rise Of Tocilizumab: Are Steroids ...
POS1435 TOCILIZUMAB IN MONOTHERAPY VS. COMBINED IN AORTITIS ASSOCIATED ...
(PDF) Health-related quality of life in patients with giant cell ...
Outcomes during and after long-term tocilizumab treatment in patients ...
Long-term efficacy and safety of tocilizumab in giant cell arteritis ...
Giant Cell Arteritis | The Effects of Treatment on Body Mass Index in ...
(PDF) Giant Cell Arteritis With Chronic Bronchitis Successfully Treated ...
AB0666 Clinical and serological outcomes of patients with giant cell ...
(PDF) Design of the Tocilizumab in Giant Cell Arteritis Trial
OP0065 TOCILIZUMAB IN VISUAL INVOLVEMENT OF GIANT CELL ARTERITIS ...
Full article: Biologic Therapies for Giant Cell Arteritis
ABS0547 IS THERE A WINDOW OF OPPORTUNITY IN THE TREATMENT OF GIANT CELL ...
Metabolic bone health considerations in giant cell arteritis and ...
Tocilizumab makes big impression in giant cell arteritis treatment | MDedge
Efficacy and safety of tocilizumab in giant cell arteritis: a single ...
Discussion - Clinical Review Report: Tocilizumab (Actemra) - NCBI Bookshelf
(PDF) Efficacy and safety of tocilizumab in giant cell arteritis: A ...
(PDF) Tocilizumab as an add-on therapy to glucocorticoids during the ...
Tocilizumab in giant cell arteritis: an update for the clini ...
GCA: Normal dose of prednisone? - Giant Cell Arteritis Treatment - YouTube
AB1318 EFFECTIVENESS OF TOCILIZUMAB IN AORTITIS AND ANEURYSMS ...
The Effects of Daily Prednisone and Tocilizumab on Hemoglobin A1c ...
OP0027 TIME TO FLARE AND GLUCOCORTICOID EXPOSURE IN PATIENTS WITH NEW ...
00560-2/asset/a3cc054b-c8fe-4bcc-acce-3698d62157f7/main.assets/gr1.gif)
00152-1/asset/5a943640-95b5-41f4-8a54-e2c600450bf0/main.assets/gr1.gif)
